Sponsor Dossier
Alexion Pharmaceuticals
Sponsor Dossier for Alexion Pharmaceuticals. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.
About
Alexion Pharmaceuticals is an Australian Private Company with ABN 59 132 343 036, registered in New South Wales. The company is currently active.
Portfolio
Alexion Pharmaceuticals has six brands on the ARTG, with all six cleared through the SEO quality gate. All six brands have Product Information on file. Three brands are PBS-listed, five brands have PBAC outcomes on record, and four brands have AusPARs on record. Notable brands include KANUMA, KOSELUGO, SOLIRIS, STRENSIQ, ULTOMIRIS, and VOYDEYA.
Therapeutic focus
— Haematology: 2 brands — Neurology: 1 brand — Endocrinology: 1 brand — Oncology: 1 brand — Rare Disease: 1 brand
PBS footprint
Three brands are PBS-listed. The portfolio last touched the PBS schedule on 1 May 2026.
Regulatory activity
The most recent PBAC outcome was 1 March 2025, with five brands holding PBAC outcomes on record. The most recent AusPAR was issued on 11 November 2024, with four brands holding AusPARs on record.